non-tnfi (Corrona LLC)
90
Structured Review
Corrona LLC
non-tnfi
Non Tnfi, supplied by Corrona LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-tnfi/non+tnfi/pm28298374-76-138-219
Average 90 stars, based on 1 article reviews
Non Tnfi, supplied by Corrona LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-tnfi/non+tnfi/pm28298374-76-138-219
Average 90 stars, based on 1 article reviews
non-tnfi - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Comparison:Article Title: Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Article Snippet: This and other Table 2 Serious infections in patients on bDMARDs, comparison between different bDMARDs (observational studies) Year of publication Study ID Registry Intervention Control aHR (intervention vs comparator/control) Risk of bias Serious Infections 2013–2016 Aaltonen 2015 J Rheum10 National Register for Biologic Treatment in Finland (ROB-FIN) RTX TNFi 1.4 (0.8 to 2.6) Low Chiang 2014 Comp methods16 Taiwan’s National Health Insurance Research Database ETA ADA 2.0 (1.1 to 3.6)* High Chiu 2014 Int J Rheum Dis11 ADA ETA 1.8 (1.2 to 2.8) High Curtis 2014 AC&R17 US Veterans (claims dataset) ABA ETA 1.1 (0.6 to 2.1) Moderate ADA 1.4 (0.9 to 2.2) IFX 2.3 (1.3 to 4.0) RTX 1.4 (0.8 to 2.6) Johnston 2013 Semin Arthr Rheum18 MarketScan (claims dataset) ABA RTX 1.2 (0.8 to †) Moderate ADA 1.1 (0.7 to 1.7) ETA 1.3 (0.8 to 2.0) Control:Article Title: Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Article Snippet: This and other Table 2 Serious infections in patients on bDMARDs, comparison between different bDMARDs (observational studies) Year of publication Study ID Registry Intervention Control aHR (intervention vs comparator/control) Risk of bias Serious Infections 2013–2016 Aaltonen 2015 J Rheum10 National Register for Biologic Treatment in Finland (ROB-FIN) RTX TNFi 1.4 (0.8 to 2.6) Low Chiang 2014 Comp methods16 Taiwan’s National Health Insurance Research Database ETA ADA 2.0 (1.1 to 3.6)* High Chiu 2014 Int J Rheum Dis11 ADA ETA 1.8 (1.2 to 2.8) High Curtis 2014 AC&R17 US Veterans (claims dataset) ABA ETA 1.1 (0.6 to 2.1) Moderate ADA 1.4 (0.9 to 2.2) IFX 2.3 (1.3 to 4.0) RTX 1.4 (0.8 to 2.6) Johnston 2013 Semin Arthr Rheum18 MarketScan (claims dataset) ABA RTX 1.2 (0.8 to †) Moderate ADA 1.1 (0.7 to 1.7) ETA 1.3 (0.8 to 2.0) |